SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast)
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Neoplasm, Breast|Congenital, Familial and Genetic Disorders
Interventions: DRUG: Alpelisib 150 MG Oral Tablet [Piqray]|DRUG: Fulvestrant
Sponsor: Borstkanker Onderzoek Groep
Collaborators: Novartis Pharma B.V.|BOOG Study Center